• Pravastatin Sodium in Transporter-Aware Assays

  2026-08-22

  Pravastatin sodium is more than an HMG-CoA reductase inhibitor for cholesterol studies. This article presents a transporter-aware framework for separating pathway-specific effects, hepatocyte exposure, extract toxicity, and botanical-drug interaction signals.

• Prion-Based Mutagenesis and Rapid Adaptation

  2026-08-22

  A 2026 Cell study shows that prion-based self-assembly of DNA repair and recombination proteins can function as a heritable, reversible switch for mutagenesis. By altering genome-fidelity activities and adaptive trajectories in yeast, this mechanism promotes rapid evolution under stress and contributes to the emergence of fluconazole resistance in Candida albicans.

• KX2-391 dihydrochloride Research Workflows

  2026-08-21

  KX2-391 dihydrochloride connects Src kinase, tubulin, HBV transcription, and BoNT/A research in one adaptable small-molecule workflow. This guide translates its concentration-dependent activity into practical oncology, virology, and neurotoxin assay designs with troubleshooting checkpoints.

• Z-VAD-FMK Workflow for Apoptosis Studies

  2026-08-20

  Build cleaner apoptosis experiments with a cell-permeable, irreversible pan-caspase inhibitor that separates caspase-dependent death from ferroptosis and other stress responses. This workflow connects Z-VAD-FMK dosing, orthogonal readouts, and the latest lens-cell ferroptosis findings to practical immune-cell and cancer research applications.

• Haloprogin for Antifungal Assay Workflows

  2026-08-20

  Haloprogin combines strong dermatophyte activity with reported effects against Candida and selected Gram-positive bacteria, making it useful for layered in vitro and topical infection studies. This guide translates historical assay parameters into reproducible workflows, formulation choices, and troubleshooting strategies for research teams using BA1790.

• Prochlorperazine-Induced Neuroleptic Malignant Syndrome

  2026-08-19

  This case report highlights neuroleptic malignant syndrome after standard-dose prochlorperazine in an older adult, despite initially unremarkable laboratory findings. It shows why medication history, neurological examination, and clinical evolution may be more informative than creatine phosphokinase elevation alone when evaluating a drug-induced neurological emergency.

• Western Secondary Antibody Dilution Buffer K4115

  2026-08-19

  Western Secondary Antibody Dilution Buffer K4115 supports consistent secondary-antibody dilution for protein detection Western blot workflows. Its BSA-, detergent-, and stabilizer-containing formulation is designed for reducing non-specific antibody binding and improving antibody stability in assays, with documented reuse and storage specifications.

• Deferiprone for Iron-Stress Assay Design

  2026-08-18

  Deferiprone enables controlled iron depletion for studies of metabolism, proliferation, apoptosis, and inflammatory signaling. This practical guide translates enterocyte iron-stress findings into reproducible workflows while highlighting applications in cancer biology, doxorubicin injury, and cerebrovascular models.

• Dextran sulfate sodium salt in DSS Colitis Models

  2026-08-18

  Dextran sulfate sodium salt (MW 35000-45000) provides a practical route to model epithelial injury, inflammation, and mucosal repair in mice. This workflow connects DSS-induced barrier disruption with the GPR35-KLF5 repair circuitry, helping researchers distinguish anti-inflammatory activity from genuine epithelial healing.

• Resazurin Sodium Salt: Reading Metabolic Viability

  2026-08-17

  Resazurin sodium salt is a fluorogenic oxidation-reduction indicator that converts cellular reducing activity into a measurable fluorescence signal. This guide explains how to interpret that signal in glutamine-dependent fibrosis models, cancer cell line toxicity assessment, and scalable viability workflows without confusing metabolism with cell number.

• Tobramycin Workflows for Gram-Negative Research

  2026-08-17

  Build reproducible Tobramycin assays around aqueous handling, controlled inocula, and quantitative MIC readouts. This research-focused guide also shows how historical aminoglycoside comparisons can strengthen antibiotic resistance research and experimental troubleshooting.

• Deferiprone Workflows for Iron-Stress Research

  2026-08-16

  Build controlled iron-deficiency, oxidative-stress, and cytotoxicity assays with Deferiprone, a water-soluble chelator suited to mechanistic cell research. This guide connects enterocyte metabolomics with cancer biology, doxorubicin-protection studies, and exploratory neurovascular models while emphasizing dose, timing, and repletion controls.

• USP42 Promotes Breast Cancer by Blocking Apoptosis

  2026-08-15

  The reference study identifies USP42 as a pro-tumorigenic deubiquitinating enzyme in breast cancer and links its activity to suppression of JNK/p38-mediated apoptosis. By combining expression analysis, USP42 silencing, inhibitor rescue experiments, and xenograft modeling, the authors provide evidence that USP42 may be a useful mechanistic target for studying apoptosis resistance.

• Necrostatin 2: A Cell-Death Assay Lens

  2026-08-14

  Necrostatin 2 (Nec-2) enables targeted interrogation of necroptosis inhibition while exposing important distinctions between kinase signaling, membrane repair, and inflammatory tissue injury. This article uses TMEM16F-dependent Kupffer cell protection as a framework for designing more discriminating assays.

• Ceftolozane/Tazobactam: Mechanism, PK, and Evidence

  2026-08-14

  The reference review examines why ceftolozane/tazobactam was developed as an antipseudomonal cephalosporin/β-lactamase inhibitor combination for resistant gram-negative infections. Its central contribution is the integration of mechanism, microbiology, pharmacokinetics, pharmacodynamics, clinical evidence, and safety considerations into a framework for interpreting this agent in complicated intraabdominal and urinary tract infections.

8105 records 1/541 page Next 12345 下5页 Last page